Dynavax Technologies Corp (NASDAQ: DVAX) started the day on Thursday, with a price increase of 6.70% at $10.99, before settling in for the price of $10.3 at the close. Taking a more long-term approach, DVAX posted a 52-week range of $9.20-$14.63.
Nevertheless, stock’s Earnings Per Share (EPS) this year is -295.00%. This publicly-traded company’s shares outstanding now amounts to $117.36 million, simultaneously with a float of $116.54 million. The organization now has a market capitalization sitting at $1.29 billion. At the time of writing, stock’s 50-day Moving Average stood at $10.01, while the 200-day Moving Average is $11.12.
Dynavax Technologies Corp (DVAX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Drug Manufacturers – Specialty & Generic Industry. Dynavax Technologies Corp’s current insider ownership accounts for 0.62%, in contrast to 95.92% institutional ownership. According to the most recent insider trade that took place on Aug 22 ’25, this organization’s Director bought 3,800 shares at the rate of 10.82, making the entire transaction reach 41,116 in total value, affecting insider ownership by 35,004. Preceding that transaction, on Aug 21 ’25, Company’s 10% Owner sold 1,094,994 for 11.03, making the whole transaction’s value amount to 12,077,784. This particular insider is now the holder of 16,696,492 in total.
Dynavax Technologies Corp (DVAX) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.02 per share during the current fiscal year. Dynavax Technologies Corp’s EPS decrease for this current 12-month fiscal period is -295.00% and is forecasted to reach 0.50 in the upcoming year.
Dynavax Technologies Corp (NASDAQ: DVAX) Trading Performance Indicators
Let’s observe the current performance indicators for Dynavax Technologies Corp (DVAX). It’s Quick Ratio in the last reported quarter now stands at 6.94. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 3.90. Similarly, its price to free cash flow for trailing twelve months is now 16.00.
In the same vein, DVAX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.38, a figure that is expected to reach 0.04 in the next quarter, and analysts are predicting that it will be 0.50 at the market close of one year from today.
Technical Analysis of Dynavax Technologies Corp (DVAX)
If we take a close look at the recent performances of Dynavax Technologies Corp (NASDAQ: DVAX), its last 5-days Average volume was 2.44 million that shows progress from its year to date volume of 1.99 million. During the previous 9 days, stock’s Stochastic %D was recorded 47.12% While, its Average True Range was 73.02.
Raw Stochastic average of Dynavax Technologies Corp (DVAX) in the period of the previous 100 days is set at 62.59%, which indicates a major fall in contrast to 82.14% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.29 that was lower than 0.32 volatility it exhibited in the past 100-days period.
